QPS, LLC

05/29/2026

'New Lyme disease vaccine LB6V reduced cases by ~70% in trials. With nearly 476,000 U.S. cases annually and expanding tick habitats, it could become the first human Lyme vaccine in decades. To learn about studies, visit https://shorturl.at/gIxWW or email [email protected]

https://shorturl.at/kDuc9

After more than two decades without a human vaccine for Lyme disease, a new candidate is showing measurable progress in clinical trials.

05/29/2026

Happy Friday! At , positive feedback from clients keeps us motivated to contunie doing excellent work. Get to know QPS global services here https://shorturl.at/mWPLv or email us at [email protected] to get started.

05/29/2026

has completed 68 biosimilar studies across Phase I-IV, supporting PK/PD, immunogenicity, and comparative efficacy programs with global expertise you can trust. For more, visit https://shorturl.at/MOJQE or email [email protected].

Would you like to sign up for updates from QPS? If so, check one or more of the options below. By checking a box and submitting the form, you are consenting to receive marketing emails from QPS Holdings, LLC, 3 Innovation Way, Newark, DE 19711, US, http://www.qps.com. You can revoke your consent to....

05/28/2026

has implemented Oracle Argus to strengthen , streamline safety case management, and enhance global adverse event reporting across . Learn more by reading our press release here: https://shorturl.at/dIhAq or email [email protected].

05/27/2026

In this month's newsletter, advance your with . Explore our expertise, global solutions, and the latest insights on the QPS Blog. https://www.qps.com/resources/newsletters/. Sign up here https://shorturl.at/j8b09

05/27/2026

At , globally recognized scientists offer a wide range of toxicity studies, as well as other safety tests that are essential for programs. Learn more by visiting https://bit.ly/3QfLuD3 or email [email protected].

20 Years of Global Toxicology Excellence. QPS offers a wide range of toxicity and drug metabolism and pharmacokinetics (DMPK) studies.

05/26/2026

India delivers high-quality research with PK/PD expertise, expert dermal evaluators, and global regulatory compliance for Phase I-IV . Learn more by visiting https://shorturl.at/HrPMC or email [email protected].

05/26/2026

is June 9-10, 2026 in London. Please reach out to Edwin van Vulpen and Bernd Saynisch to book a meeting and find out how can accelerate your next . Learn more about QPS services https://www.qps.com/ or email [email protected].

05/22/2026

It's Friday! loves hearing positive feedback from clients that have great experiences working with our teams. Explore QPS global services here https://shorturl.at/mWPLv or email us at [email protected] to get started.

05/21/2026

Explore insights in the new Video Podcast series. Discover imaging services in the latest monthly newsletter, https://www.qps.com/resources/newsletters/. Not getting our newsletters? Sign up here https://shorturl.at/j8b09